Erratum to: Therapeutic epigenome editing: safety and quality considerations of a new class of gene-targeted medicines

This erratum contains corrections to the article: Bachtarzi H, Farries T. Therapeutic epigenome editing: safety and quality considerations of a new class of gene-targeted medicines. Cell & Gene Therapy Insights 2024; 10(9), 1257–1272.

In the version of this article initially published, there was an error in the reference numbers. The correction is listed in full below. The corrections were made to the PDF version of this article as of April 10, 2025; the amended article may be accessed here.

Please enter your email to access content Read now